Big Gain For Adamis Pharmaceuticals Corporation
Tue, Aug 01, 2023 at 07:37 PM
Adamis Pharmaceuticals Corporation (ADMP:NASDAQ) jumped higher at $3.99, representing a gain of 179%. On Tue, Aug 01, 2023, ADMP:NASDAQ hit a New 2-Week High of $3.99. The stock got featured on our News Catalysts scanner on Fri, Jul 28, 2023 at 09:46 AM in the 'BIOTECH' category. From Tue, Jul 18, 2023, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Aug 01, 2023 at $8.28 with a volume of 20M+.
About Adamis Pharmaceuticals Corporation (ADMP:NASDAQ)
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Top 10 Gainers:
- Adamis Pharmaceuticals Corporation (ADMP:NASDAQ), 179.02%
- Yellow Corporation (YELL:NASDAQ), 121.59%
- Motorsport Games Inc. (MSGM:NASDAQ), 92.42%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 64.38%
- American Superconductor Corporation (AMSC:NASDAQ), 60.02%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- AEye Inc. (LIDR:NASDAQ), 43.67%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 40.23%
- Xos Inc. (XOS:NASDAQ), 31.19%
- Rigetti Computing Inc. (RGTI:NASDAQ), 30.52%